Advertisement

Topics

OTC Switch Interest Cooled By Study Costs To Update Safety Data

07:24 EDT 5 Jul 2017 | SCRIP

Firms often are hesitant to prepare Rx-to-OTC switch applications because safety and efficacy data for their products are over a...

      

Related Stories

 

Original Article: OTC Switch Interest Cooled By Study Costs To Update Safety Data

NEXT ARTICLE

More From BioPortfolio on "OTC Switch Interest Cooled By Study Costs To Update Safety Data"

Advertisement
Quick Search
Advertisement
Advertisement